New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.
D000818:Animals; D001947:Breeding / Q000331:legislation & jurisprudence; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D051379:Mice; D008822:Mice, Transgenic / Q000276:immunology* / Q000821:virology; D011051:Poliomyelitis / Q000235:genetics / Q000821:virology*; D017955:Poliovirus / Q000235:genetics / Q000472:pathogenicity*; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects / Q000145:classification / Q000633:toxicity*; D011991:Receptors, Virus / Q000235:genetics; D018570:Risk Assessment; D014944:World Health Organization
D011055:Poliovirus Vaccine, Oral; D011991:Receptors, Virus